The Unit Dose Packaging Market Size is valued at USD 27.2 Bn in 2023 and is predicted to reach USD 49.1 Bn by the year 2031 at an 7.9% CAGR during the forecast period for 2024-2031.
Unit dose packaging simplifies drug administration by helping patients stick to their treatment schedules. Providing pre-measured doses with clear instructions lowers the risk of error and increases compliance. This packaging solution streamlines the process of administering and dispensing pharmaceuticals in healthcare settings, improving accuracy and efficiency. Medical professionals can deliver drugs rapidly without having to spend time sorting pill boxes or estimating dosages, which reduces the potential for dispensing errors. Each dose is labeled with critical information, such as the medication's name, potency, and expiration date, to improve accountability and traceability.
A report by the India Brand Equity Foundation (IBEF) in June 2021 highlighted that India's pharmaceutical industry supplies over 50% of the world's demand for various vaccines, 40% of the generic drug demand in the United States, and more than 25% of all medications in the United Kingdom. This strong global presence is supported by increased research and development (R&D) expenditures, enabling manufacturers to create innovative unit-dose packaging solutions with unique features, functions, and advantages. By leveraging advanced materials, technologies, and design principles, companies can differentiate themselves in the market and adapt to evolving consumer preferences and industry trends.
These innovative packaging designs may include tamper-evident seals, child-resistant closures, dose-tracking devices, and enhanced usability, improving product safety, convenience, and user experience. R&D efforts in unit-dose packaging focus on meeting the stringent regulations and quality standards set by government agencies and trade organizations. Consequently, the rise in research and development activities is a key driver of growth in the pharmaceutical unit-dose packaging market.
The Unit Dose Packaging Market is segmented based on the technology application, and end-user. Based on the Form, the market is divided into liquid, solid, powder, and gel. Based on the material type, the market is divided into plastic, glass, paper, and aluminium. Based on the product type, the market is divided into blister packs, sachets & strip packs, ampoules & vials, and other, product types. Based on the end-use industry, the market is divided into pharmaceuticals, cosmetic & personal care, and nutraceuticals.
Based on the Form, the market is divided into liquid, solid, powder, and gel. Among these, the liquid segment is expected to have the highest growth rate during the forecast period. Liquid medications are commonly used across various therapeutic areas, including syrups, injectables, eye drops, inhalers, and vaccines. The versatility of liquid medications contributes to their dominant presence in the market. The rising demand for injectable drugs, biologics, and vaccines has significantly increased the use of liquid unit dose packaging, especially with the growing focus on personalized medicine and precision dosing. Liquid medications are more susceptible to contamination and degradation compared to solid forms.
Unit dose packaging, which provides single-use, sealed doses, helps maintain the sterility and integrity of the medication, especially in the case of sensitive pharmaceuticals like injectables and ophthalmic solutions. Regulatory bodies impose strict guidelines on the packaging of liquid medications to ensure safety, sterility, and compliance. Unit dose packaging meets these stringent requirements by providing sealed, tamper-evident, and properly labeled doses.
Based on the product type, the market is divided into blister packs, sachets & strip packs, ampoules & vials, and other, product types. Among these, the blister pack segment dominates the market. Blister packs are used for a wide variety of medications, particularly for oral solid doses like tablets and capsules. They can also be used for liquid-filled capsules and certain other forms of medications, making them adaptable to different needs. Blister packs are compact, lightweight, and easy to carry, making them ideal for patient use, particularly for on-the-go consumption. They also offer a clear visual of the medication, which helps with patient compliance. Blister packs provide strong protection against external factors such as moisture, air, and contaminants, helping to preserve the medication’s potency and extend its shelf life. The individually sealed compartments ensure that each dose remains untouched until use, reducing the risk of contamination. Blister packaging is inherently tamper-evident, offering visible signs of any attempted tampering, which enhances product safety and compliance with regulatory requirements.
North America is home to several major pharmaceutical companies that invest heavily in innovative drug development and packaging solutions. The pharmaceutical sector's focus on patient safety, drug integrity, and regulatory compliance supports the dominance of unit dose packaging in the region. The region has a high demand for both over-the-counter (OTC) and prescription drugs due to the aging population, high incidence of chronic diseases, and a large healthcare-seeking population. Unit dose packaging is ideal for precise and safe medication administration, making it highly suitable for the growing pharmaceutical market. The U.S. FDA (Food and Drug Administration) and other regulatory agencies in North America impose stringent regulations on drug packaging to ensure safety, traceability, and tamper-evidence. Unit dose packaging helps meet these regulations by providing pre-measured doses with proper labeling and tamper-evident features. Healthcare providers in North America emphasize patient safety, and unit dose packaging reduces medication errors, contamination risks, and dosage confusion, making it a preferred choice in the region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 27.2 Bn |
|
Revenue Forecast In 2031 |
USD 49.1 Bn |
|
Growth Rate CAGR |
CAGR of 7.9% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, Volume (KT), and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Form, Material Type, Product Type, End-use Industry |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Pfizer Inc., Amcor Plc, Corning Incorporated, West Pharmaceutical Services, Stevanato Group, Gerresheimer Ag, Schott, Nipro, Constantia Flexibles, Klockner Pentaplast, Sonic Packaging Industries Inc., Sharp Services, Llc, Tekni-Plex, Inc., Thermo-Pak Co. Inc., Aphena Pharma Solutions, Pacific Vial Manufacturing Inc., Health Care Logistics, Inc., Ultra Seal Corporation, Safecore Health, Unit Pack, Jones Healthcare Group, Ropack Inc., Rx Systems, Inc., James Alexander Corporation, Pharmacy Automation Supplies Catalent Inc, Adelphi Healthcare Packaging, Berry Global Inc, Aptar Group Inc, BD (Becton, Dickinson, and Company), Nemera, MediSafe, Omnicare Inc., AccuStar Packaging, Schaefer Technologies Inc., Pharmapack, Paragon Healthcare, Lonza, Systech International, Vetter Pharma-Fertigung GmbH & Co. KG. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Unit Dose Packaging Market Snapshot
Chapter 4. Global Unit Dose Packaging Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Unit Dose Packaging Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Unit Dose Packaging Industry Trends
Chapter 5. Unit Dose Packaging Market Segmentation 1: By Form, Estimates & Trend Analysis
5.1. Market Share by Form, 2023 & 2031
5.2. Market Size (Value US$ Mn & Volume (KT)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Form:
5.2.1. Liquid
5.2.2. Solid
5.2.3. Powder
5.2.4. Gel
Chapter 6. Unit Dose Packaging Market Segmentation 2: By Material Type, Estimates & Trend Analysis
6.1. Market Share by Material Type, 2023 & 2031
6.2. Market Size (Value US$ Mn & Volume (KT)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Material Types:
6.2.1. Plastic
6.2.1.1. Polyvinyl Chloride
6.2.1.2. Polyethylene
6.2.1.3. Polypropylene
6.2.1.4. Polyethylene Terephthalate
6.2.1.5. Other Plastic Films
6.2.2. Glass
6.2.3. Paper & Paper Board
6.2.4. Aluminium
6.2.5. Other Material Types
Chapter 7. Unit Dose Packaging Market Segmentation 3: By Product Type, Estimates & Trend Analysis
7.1. Market Share by Product Type, 2023 & 2031
7.2. Market Size (Value US$ Mn & Volume (KT)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Types:
7.2.1. Blister Pack
7.2.2. Sachets & Strip Packs
7.2.3. Ampoules & Vials
7.2.4. Other Product Types
Chapter 8. Unit Dose Packaging Market Segmentation 4: By End-Use Industry, Estimates & Trend Analysis
8.1. Market Share by End-Use Industry, 2023 & 2031
8.2. Market Size (Value US$ Mn & Volume (KT)) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Use Industrys:
8.2.1. Pharmaceuticals
8.2.2. Cosmetic & Personal Care
8.2.3. Nutraceuticals
8.2.4. Other End-Use Industries
Chapter 9. Unit Dose Packaging Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Unit Dose Packaging Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Form, 2024-2031
9.2.3. North America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Material Type, 2024-2031
9.2.4. North America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Product Type, 2024-2031
9.2.5. North America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by End-Use Industry, 2024-2031
9.3. Europe
9.3.1. Europe Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Form, 2024-2031
9.3.3. Europe Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Material Type, 2024-2031
9.3.4. Europe Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Product Type, 2024-2031
9.3.5. Europe Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by End-Use Industry, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Form, 2024-2031
9.4.3. Asia Pacific Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Material Type, 2024-2031
9.4.4. Asia Pacific Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts By Product Type, 2024-2031
9.4.5. Asia Pacific Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by End-Use Industry, 2024-2031
9.5. Latin America
9.5.1. Latin America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Form, 2024-2031
9.5.3. Latin America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Material Type, 2024-2031
9.5.4. Latin America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Product Type, 2024-2031
9.5.5. Latin America Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by End-Use Industry, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Form, 2024-2031
9.6.3. Middle East & Africa Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Material Type, 2024-2031
9.6.4. Middle East & Africa Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by Product Type, 2024-2031
9.6.5. Middle East & Africa Unit Dose Packaging Market Revenue (US$ Million) & Volume (KT) Estimates and Forecasts by End-Use Industry, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Amcor Plc
10.2.3. Corning Incorporated
10.2.4. West Pharmaceutical Services
10.2.5. Stevanato Group
10.2.6. Gerresheimer Ag
10.2.7. Schott
10.2.8. Nipro
10.2.9. Constantia Flexibles
10.2.10. Klockner Pentaplast
10.2.11. Sonic Packaging Industries Inc.
10.2.12. Sharp Services, Llc
10.2.13. Tekni-Plex, Inc.
10.2.14. Thermo-Pak Co. Inc.
10.2.15. Aphena Pharma Solutions
10.2.16. Pacific Vial Manufacturing Inc.
10.2.17. Health Care Logistics, Inc.
10.2.18. Ultra Seal Corporation
10.2.19. Safecore Health
10.2.20. Unit Pack
10.2.21. Jones Healthcare Group
10.2.22. Ropack Inc.
10.2.23. Rx Systems, Inc.
10.2.24. James Alexander Corporation
10.2.25. Pharmacy Automation Supplies
10.2.26. Catalent Inc
10.2.27. Adelphi Healthcare Packaging
10.2.28. Berry Global Inc
10.2.29. Aptar Group Inc
10.2.30. BD (Becton, Dickinson, and Company)
10.2.31. Nemera
10.2.32. MediSafe
10.2.33. Omnicare Inc.
10.2.34. AccuStar Packaging
10.2.35. Schaefer Technologies Inc.
10.2.36. Pharmapack
10.2.37. Paragon Healthcare
10.2.38. Lonza
10.2.39. Systech International
10.2.40. Vetter Pharma-Fertigung GmbH & Co. KG
Global Unit Dose Packaging Market- By Form
Global Unit Dose Packaging Market – By Material Type
Global Unit Dose Packaging Market – By Product Type
Global Unit Dose Packaging Market – By End-Use Industry
Global Unit Dose Packaging Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
